Lipid signals and insulin resistance

Clinical Lipidology

Volumn 8, Issue 6, 2013, Pages 659-667

  Zhang, Chongben ^a   Klett, Eric L ^b   Coleman, Rosalind A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

acyl CoA; ceramide; diacylglycerol; lysophosphatidic acid; phosphatidic acid

Indexed keywords

ACYL COENZYME A; DIACYLGLYCEROL; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROLIPID; INSULIN; LIPID; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC ACID; PROTEIN KINASE C; TRIACYLGLYCEROL;

CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESTERIFICATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; OBESITY; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 84889566588     PISSN: 17584299     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.13.67     Document Type: Review

References (72)

1. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79 (2003 (Pubitemid 36026281)
2. Reaven G. The insulin resistance syndrome: Definition and dietary approaches to treatment. Annu. Rev. Nutr. 25, 391-406 (2005 (Pubitemid 41209007)
3. Mikhail N. The metabolic syndrome: Insulin resistance. Curr. Hypertens. Rep. 11, 156-158 (2009
4. Muoio DM, Newgard C. Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in Type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 193-205 (2008 (Pubitemid 351301824)
5. Taubes G. Insulin resistance. Prosperity's plague. Science 325, 256-260 (2009
6. Muoio DM. Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? Biochim. Biophys. Acta 1801(3), 281-288 (2010
7. Schooneman MG, Vaz FM, Houten SM, Soeters M Acylcarnitines: Reflecting or inflicting insulin resistance? Diabetes 62, 1-8 (2013
8. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 8, 923-934 (2008
9. Coen PM, Goodpaster B. Role of intramyocelluar lipids in human health. Trends Endocrinol. Metab. 23, 391-398 (2012
10. Jornayvaz FR, Shulman G. Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab. 15, 574-584 (2012
11. Savage DB, Petersen KF, Shulman G. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507-520 (2007 (Pubitemid 47084679)
12. Coleman RA, Mashek D. Mammalian triacylglycerol metabolism: Synthesis, lipolysis, and signaling. Chem. Rev. 111, 6359-6386 (2011
13. Nagle CA, An J, Shiota M et al. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J. Biol. Chem. 282, 14807-14815 (2007 (Pubitemid 47093356)
14. Neschen S, Morino K, Hammond LE et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl- CoA:glycerol-sn-3- phosphate acyltransferase 1 knockout mice. Cell Metab. 2, 55-65 (2005 (Pubitemid 43239825)
15. Nakanaga K, Hama K, Aoki J. Autotaxin - An LPA producing enzyme with diverse functions. J. Biochem. 148, 13-24 (2010
16. McIntyre TM, Pontsler AV, Silva AR et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl Acad. Sci. USA 100, 131-136 (2003 (Pubitemid 36078041)
17. Stapleton CM, Mashek DG, Wang S et al. Lysophosphatidic acid activates peroxisome proliferator activated receptor-gamma in CHO cells that over-express glycerol 3-phosphate acyltransferase-1. PLoS ONE 6, e18932 (2011
18. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med. 331, 1188-1193 (1994 (Pubitemid 24331336)
19. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942-1945 (2001 (Pubitemid 33101594)
20. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 3, 393-402 (2006 (Pubitemid 43811780)
21. Gulati P, Thomas G. Nutrient sensing in the mTOR/S6K1 signalling pathway. BioChem. Soc. Trans. 35, 236-238 (2007 (Pubitemid 46596477)
22. Loewith R, Jacinto E, Wullschleger S et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468 (2002 (Pubitemid 35284167)
23. Sarbassov DD, Guertin DA, Ali SM, Sabatini D. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005 (Pubitemid 40262113)
24. Toschi A, Lee E, Xu L, Garcia A, Gadir N, Foster D. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: Competition with rapamycin. Mol. Cell Biol. 29, 1411-1420 (2009
25. Shulga YV, Topham MK, Epand R. Regulation and functions of diacylglycerol kinases. Chem. Rev. 111, 6186-6208 (2011
26. Merida I, Avila-Flores A, Merino E. Diacylglycerol kinases: At the hub of cell signalling. Biochem. J. 409, 1-18 (2008
27. Chibalin AV, Leng Y, Vieira E et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132, 375-386 (2008 (Pubitemid 351191998)
28. Zhang C, Wendel AA, Keogh MR, Harris TE, Chen J, Coleman R. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc. Natl Acad. Sci. USA 109, 1667-1672 (2012
29. Divecha N, Lander DJ, Scott TW, Irvine R. Molecular species analysis of 1,2-diacylglycerols and phosphatidic acid formed during bombesin stimulation of Swiss 3T3 cells. Biochim. Biophys. Acta 1093, 184-188 (1991
30. Lee C, Fisher SK, Agranoff BW, Hajra A. Quantitative analysis of molecular species of diacylglycerol and phosphatidate formed upon muscarinic receptor activation of human SK-N-SH neuroblastoma cells. J. Biol. Chem. 266, 22837-22846 (1991 (Pubitemid 21908727)
31. Beckman BS, Mallia C, Clejan S. Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin. Biochem. J. 314(Pt 3), 861-867 (1996 (Pubitemid 26097748)
32. Pettitt TR, Martin A, Horton T, Liossis C, Lord JM, Wakelam M. Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells. J. Biol. Chem. 272, 17354-17359 (1997 (Pubitemid 27311161)
33. Samuel VT, Liu ZX, Wang A et al. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin Invest. 117, 739-745 (2007 (Pubitemid 46348532)
34. Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230-50236 (2002 (Pubitemid 36042170)
35. Samuel VT, Petersen KF, Shulman G. Lipid-induced insulin resistance: Unravelling the mechanism. Lancet 375, 2267-2277 (2010
36. Werner ED, Lee J, Hansen L, Yuan M, Shoelson S. Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J. Biol. Chem. 279, 35298-35305 (2004 (Pubitemid 39100527)
37. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005-2011 (2002 (Pubitemid 34729001)
38. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien L. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40, 1397-1403 (1991
39. Hoeg LD, Sjoberg KA, Jeppesen J et al. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes 60, 64-73 (2010
40. Vistisen B, Hellgren LI, Vadset T et al. Effect of gender on lipid-induced insulin resistance in obese subjects. Eur. J. Endocrinol. 158, 61-68 (2008 (Pubitemid 351211041)
41. Anastasiou CA, Kavouras SA, Lentzas Y, Gova A, Sidossis LS, Melidonis A. Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans. Metabolism 58, 1636-1642 (2009
42. Perreault L, Bergman BC, Hunerdosse DM, Eckel R. Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes. Obesity (Silver Spring) 18, 2093-2100 (2010
43. Amati F, Dube JJ, Alvarez-Carnero E et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: Another paradox in endurance-trained athletes? Diabetes 60, 2588-2597 (2011
44. Coen PM, Hames KC, Leachman EM et al. Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity. Obesity (Silver Spring) doi:10.1002/oby.20381 (2013) (Epub ahead of print
45. Timmers S, Nabben M, Bosma M et al. Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity. Proc. Natl Acad. Sci. USA 109, 11711-11716 (2012
46. Minehira K, Young SG, Villanueva CJ et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J. Lipid Res. 49, 2038-2044 (2008
47. Monetti M, Levin MC, Watt MJ et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6, 69-78 (2007 (Pubitemid 46995777)
48. Monetti M, Levin MC, Watt MJ et al. Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity. Proc. Natl Acad. Sci. USA 108, e523; author reply: E524 (2011
49. Farese RV Jr, Zechner R, Newgard CB, Walther T. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 15, 570-573 (2012
50. Li LO, Klett EL, Coleman R. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta 1801(3), 246-251 (2009
51. Soupene E, Kuypers F. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 233, 507-521 (2008 (Pubitemid 351657352)
52. Chen MT, Kaufman LN, Spennetta T, Shrago E. Effects of high fat-feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metabolism 41, 564-569 (1992
53. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen E. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46, 1768-1774 (1997 (Pubitemid 27456409)
54. Ellis BA, Poynten A, Lowy AJ et al. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 279, e554-e560 (2000
55. Wright LE, Brandon AE, Hoy AJ et al. Amelioration of lipid-induced insulin resistance in rat skeletal muscle by overexpression of Pgc-1beta involves reductions in long-chain acyl-CoA levels and oxidative stress. Diabetologia 54, 1417-1426 (2011
56. McGarry J. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes 51, 7-18 (2002 (Pubitemid 34517974)
57. Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45-56 (2008
58. Zhang Y, Li Y, Niepel MW et al. Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance. Proc. Natl Acad. Sci. USA 109, 5417-5422 (2012
59. Chavez JA, Summers S. A ceramide-centric view of insulin resistance. Cell Metab. 15, 585-594 (2012
60. Cazzolli R, Carpenter L, Biden TJ, Schmitz- Peiffer C. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 50, 2210-2218 (2001 (Pubitemid 33641903)
61. Powell DJ, Hajduch E, Kular G, Hundal H. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol. Cell Biol. 23, 7794-7808 (2003 (Pubitemid 37271476)
62. Fox TE, Houck KL, O'Neill SM et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J. Biol. Chem. 282, 12450-12457 (2007 (Pubitemid 47100622)
63. Hajduch E, Turban S, Le Liepvre X et al. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Biochem. J. 410, 369-379 (2008 (Pubitemid 351346195)
64. Holland WL, Bikman BT, Wang LP et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858-1870 (2011
65. Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer P. Plasma ceramides are elevated in female children and adolescents with Type 2 diabetes. J. Pediatr. Endocrinol. Metab. 26(9-10), 995-998 (2013
66. Holland WL, Brozinick JT, Wang LP et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5, 167-179 (2007
67. Ussher JR, Koves TR, Cadete VJ et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453-2464 (2010
68. Prasad SS, Garg A, Agarwal A. Enzymatic activities of the human AGPAT isoform 3 and isoform 5: Localization of AGPAT5 to mitochondria. J. Lipid Res. 52, 451-462 (2010
69. Freyberg Z, Sweeney D, Siddhanta A, Bourgoin S, Frohman M, Shields D. Intracellular localization of phospholipase D1 in mammalian cells. Mol. Biol. Cell 12, 943-955 (2001 (Pubitemid 33051990)
70. Goto K, Hozumi Y, Nakano T, Saino-Saito S, Martelli A. Lipid messenger, diacylglycerol, and its regulator, diacylglycerol kinase, in cells, organs, and animals: History and perspective. Tohoku J. Exp. Med. 214, 199-212 (2008 (Pubitemid 351513532)
71. Zhang J, Gao Z, Yin J, Quon MJ, Ye J. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J. Biol. Chem. 283, 35375-35382 (2008
72. Rosner M, Hengstschlager M. Detection of cytoplasmic and nuclear functions of mTOR by fractionation. Methods Mol. Biol. 821, 105-124 (2011)